Hospital Mater Dei S.A.

BOVESPA:MATD3 Stok Raporu

Piyasa değeri: R$1.5b

Hospital Mater Dei Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Hospital Mater Dei's earnings have been declining at an average annual rate of -27.8%, while the Healthcare industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 31% per year.

Anahtar bilgiler

-27.8%

Kazanç büyüme oranı

-30.9%

EPS büyüme oranı

Healthcare Sektör Büyümesi11.6%
Gelir büyüme oranı31.0%
Özkaynak getirisi-22.1%
Net Marj-16.1%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 10
Hospital Mater Dei S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

What You Can Learn From Hospital Mater Dei S.A.'s (BVMF:MATD3) P/E After Its 26% Share Price Crash

Apr 27
What You Can Learn From Hospital Mater Dei S.A.'s (BVMF:MATD3) P/E After Its 26% Share Price Crash

Robust Earnings May Not Tell The Whole Story For Hospital Mater Dei (BVMF:MATD3)

Aug 19
Robust Earnings May Not Tell The Whole Story For Hospital Mater Dei (BVMF:MATD3)

Gelir ve Gider Dağılımı

Hospital Mater Dei nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BOVESPA:MATD3 Gelir, gider ve kazançlar (BRL Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 242,278-3683020
31 Mar 242,2461352970
31 Dec 232,1881202960
30 Sep 232,1591082950
30 Jun 232,0641132990
31 Mar 231,9441042920
31 Dec 221,7631042690
30 Sep 221,5391112370
30 Jun 221,3061211960
31 Mar 221,1401451570
31 Dec 211,0241451340
30 Jun 218991301240
31 Mar 21774841200
31 Dec 20718731170
31 Dec 197331381170
31 Dec 18627124960
31 Dec 17600108790
31 Dec 1652586690
31 Dec 1543053610
31 Dec 1431951500
31 Dec 1329353420

Kaliteli Kazançlar: MATD3 is currently unprofitable.

Büyüyen Kar Marjı: MATD3 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MATD3 is unprofitable, and losses have increased over the past 5 years at a rate of 27.8% per year.

Büyüme Hızlandırma: Unable to compare MATD3's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: MATD3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (67.7%).


Özkaynak Getirisi

Yüksek ROE: MATD3 has a negative Return on Equity (-22.07%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin